as 3201 has been researched along with imidazolidines in 1 studies
| Studies (as 3201) | Trials (as 3201) | Recent Studies (post-2010) (as 3201) | Studies (imidazolidines) | Trials (imidazolidines) | Recent Studies (post-2010) (imidazolidines) |
|---|---|---|---|---|---|
| 33 | 7 | 12 | 1,666 | 186 | 358 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hotta, N | 1 |
1 review(s) available for as 3201 and imidazolidines
| Article | Year |
|---|---|
[Progress on the drug therapy for diabetic microangiopathies: aldose reductase inhibitor].
Topics: Aldehyde Reductase; Animals; Clinical Trials as Topic; Diabetic Angiopathies; Drug Design; Humans; Imidazolidines; Polymers; Polymorphism, Genetic; Pyrazines; Rhodanine; Spiro Compounds; Thiazolidines | 2005 |